Genovese Burford & Brothers Wealth & Retirement Plan Management LLC held its stake in Clorox Company (The) (NYSE:CLX) during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 860 shares of the company’s stock at the end of the second quarter. Genovese Burford & Brothers Wealth & Retirement Plan Management LLC’s holdings in Clorox Company (The) were worth $114,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in the stock. BlackRock Inc. increased its stake in Clorox Company (The) by 1,402.2% in the first quarter. BlackRock Inc. now owns 10,390,206 shares of the company’s stock worth $1,400,912,000 after buying an additional 9,698,542 shares during the last quarter. Parnassus Investments CA acquired a new stake in Clorox Company (The) during the first quarter worth $434,255,000. Vanguard Group Inc. increased its stake in Clorox Company (The) by 4.8% in the first quarter. Vanguard Group Inc. now owns 14,164,716 shares of the company’s stock worth $1,909,829,000 after buying an additional 649,766 shares during the last quarter. Morgan Stanley increased its stake in Clorox Company (The) by 31.9% in the first quarter. Morgan Stanley now owns 996,369 shares of the company’s stock worth $134,342,000 after buying an additional 241,210 shares during the last quarter. Finally, WINTON GROUP Ltd increased its stake in Clorox Company (The) by 762.4% in the first quarter. WINTON GROUP Ltd now owns 228,197 shares of the company’s stock worth $28,566,000 after buying an additional 201,737 shares during the last quarter. Institutional investors own 70.29% of the company’s stock.

Shares of Clorox Company (NYSE:CLX) opened at 133.94 on Friday. The firm’s 50 day moving average is $133.72 and its 200-day moving average is $133.47. The company has a market cap of $17.29 billion, a PE ratio of 25.11 and a beta of 0.40. Clorox Company has a 1-year low of $111.24 and a 1-year high of $141.76.

Clorox Company (The) (NYSE:CLX) last posted its earnings results on Thursday, August 3rd. The company reported $1.53 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.49 by $0.04. Clorox Company (The) had a net margin of 11.74% and a return on equity of 190.67%. The business had revenue of $1.65 billion for the quarter, compared to analysts’ expectations of $1.65 billion. During the same period in the prior year, the company posted $1.30 EPS. The business’s revenue for the quarter was up 2.9% compared to the same quarter last year. Equities analysts expect that Clorox Company will post $5.68 earnings per share for the current year.

TRADEMARK VIOLATION WARNING: This story was originally published by Daily Political and is the property of of Daily Political. If you are viewing this story on another domain, it was illegally stolen and republished in violation of US and international copyright and trademark legislation. The original version of this story can be read at https://www.dailypolitical.com/2017/08/11/genovese-burford-brothers-wealth-retirement-plan-management-llc-continues-to-hold-position-in-clorox-company-the-clx.html.

Several brokerages have commented on CLX. Vetr downgraded shares of Clorox Company (The) from a “buy” rating to a “hold” rating and set a $139.67 price objective for the company. in a research report on Tuesday, April 18th. Jefferies Group LLC began coverage on shares of Clorox Company (The) in a research report on Tuesday, April 18th. They set a “hold” rating and a $138.00 price objective for the company. BMO Capital Markets restated a “buy” rating and set a $136.00 price objective on shares of Clorox Company (The) in a research report on Thursday, May 4th. BidaskClub downgraded shares of Clorox Company (The) from a “hold” rating to a “sell” rating in a research report on Wednesday, July 5th. Finally, Deutsche Bank AG restated a “hold” rating and set a $137.00 price objective (up from $126.00) on shares of Clorox Company (The) in a research report on Saturday, July 22nd. Two analysts have rated the stock with a sell rating, ten have given a hold rating and three have given a buy rating to the company. Clorox Company (The) presently has a consensus rating of “Hold” and a consensus target price of $129.05.

Clorox Company (The) Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Company (The) (NYSE:CLX).

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.